Ph.D., Divisional Vice President, Applied Research & Technology, Abbott Diagnostics
Dr. Hackett manages Diagnostics R&D groups in the U.S., Japan and China. Primary areas of focus include: Infectious Diseases, Cardiovascular, Oncology, Clinical Chemistry, Biologics Design, and New Technologies. John had an integral role in development of HIV/hepatitis global surveillance, assessment of the impact of genetic variation on nucleic acid and serological testing technologies, and research-phase development of serological assays for diagnostics and blood screening. He also leads the Abbott-sponsored partnership with the University of California, San Francisco, the UCSF/Abbott Virus Diagnostics and Discovery Center. John received his Ph.D. in Immunology from the University of Texas Southwestern Medical Center at Dallas and completed his postdoctoral training at The University of Chicago. He joined Abbott in 1992 and is a Senior Research Fellow in Abbott Volwiler Society. John has more than 120 scientific publications and issued/pending patents.
Challenges Associated With Development of Diagnostics to Emerging Agents
This session will cover the role of viral surveillance and discovery as a foundation for developing infectious disease tests and the multitude of challenges associated with rapid development of new diagnostic tests to address emerging threats.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: This session will cover new technologies and methods for detection of infectious disease outbreaks, including internet-based and laboratory testing, and the decision process to move forward with new commercial diagnostic / therapeutic products. It will also highlight public health surveillance and response to emerging agents with a discussion of the challenges and novel approaches.